FDA Says Gout Drug Uloric Has Increased Death Risk Compared To Alternative
SILVER SPRING, Md. — The Food and Drug Administration on Feb. 21 said it concluded that there is an increased risk of death from the use of Uloric brand febuxostate to...To view the full article, register now.
Already a subscriber? Click here to view full article